• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸化 HDAC6 的相分离驱动三阴性乳腺癌中染色质结构的异常。

Phase separation of phospho-HDAC6 drives aberrant chromatin architecture in triple-negative breast cancer.

机构信息

Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University, Guangzhou, China.

出版信息

Nat Cancer. 2024 Nov;5(11):1622-1640. doi: 10.1038/s43018-024-00816-y. Epub 2024 Aug 28.

DOI:10.1038/s43018-024-00816-y
PMID:39198689
Abstract

How dysregulated liquid-liquid phase separation (LLPS) contributes to the oncogenesis of female triple-negative breast cancer (TNBC) remains unknown. Here we demonstrate that phosphorylated histone deacetylase 6 (phospho-HDAC6) forms LLPS condensates in the nuclei of TNBC cells that are essential for establishing aberrant chromatin architecture. The disordered N-terminal domain and phosphorylated residue of HDAC6 facilitate effective LLPS, whereas nuclear export regions exert a negative dominant effect. Through phase-separation-based screening, we identified Nexturastat A as a specific disruptor of phospho-HDAC6 condensates, which effectively suppresses tumor growth. Mechanistically, importin-β interacts with phospho-HDAC6, promoting its translocation to the nucleus, where 14-3-3θ mediates the condensate formation. Disruption of phospho-HDAC6 LLPS re-established chromatin compartments and topologically associating domain boundaries, leading to disturbed chromatin loops. The phospho-HDAC6-induced aberrant chromatin architecture affects chromatin accessibility, histone acetylation, RNA polymerase II elongation and transcriptional profiles in TNBC. This study demonstrates phospho-HDAC6 LLPS as an emerging mechanism underlying the dysregulation of chromatin architecture in TNBC.

摘要

磷酸化组蛋白去乙酰化酶 6(phospho-HDAC6)如何失调液-液相分离(LLPS)导致女性三阴性乳腺癌(TNBC)的发生尚不清楚。在这里,我们证明磷酸化组蛋白去乙酰化酶 6(phospho-HDAC6)在 TNBC 细胞的核中形成 LLPS 凝聚物,这对于建立异常染色质结构是必不可少的。HDAC6 的无序 N 端结构域和磷酸化残基有助于有效的 LLPS,而核输出区域则产生负显性效应。通过基于相分离的筛选,我们鉴定出 Nexturastat A 是磷酸化 HDAC6 凝聚物的特异性破坏剂,可有效抑制肿瘤生长。在机制上,importin-β 与 phospho-HDAC6 相互作用,促进其易位到核内,在核内,14-3-3θ 介导凝聚物的形成。破坏 phospho-HDAC6 的 LLPS 可重建染色质隔室和拓扑关联结构域边界,导致染色质环紊乱。phospho-HDAC6 诱导的异常染色质结构会影响 TNBC 中的染色质可及性、组蛋白乙酰化、RNA 聚合酶 II 延伸和转录谱。本研究表明,phospho-HDAC6 的 LLPS 是 TNBC 中染色质结构失调的一种新机制。

相似文献

1
Phase separation of phospho-HDAC6 drives aberrant chromatin architecture in triple-negative breast cancer.磷酸化 HDAC6 的相分离驱动三阴性乳腺癌中染色质结构的异常。
Nat Cancer. 2024 Nov;5(11):1622-1640. doi: 10.1038/s43018-024-00816-y. Epub 2024 Aug 28.
2
Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation.原花青素 G 通过糖原合酶激酶 3β 介导的 SNAIL 和组蛋白去乙酰化酶 6 调控的波形蛋白降解抑制三阴性乳腺癌细胞的上皮间质转化。
Int J Mol Sci. 2022 Jan 31;23(3):1672. doi: 10.3390/ijms23031672.
3
Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer.靶向热休克蛋白90-组蛋白去乙酰化酶6调控网络对乳腺癌进行精准治疗
Int J Biol Sci. 2017 Apr 8;13(4):505-517. doi: 10.7150/ijbs.18834. eCollection 2017.
4
Impact of HDAC6-mediated progesterone receptor expression on the response of breast cancer cells to hormonal therapy.组蛋白去乙酰化酶 6 介导的孕激素受体表达对乳腺癌细胞对激素治疗反应的影响。
Eur J Pharmacol. 2024 Nov 15;983:177001. doi: 10.1016/j.ejphar.2024.177001. Epub 2024 Sep 14.
5
Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor.Tektin4 缺失通过 HDAC6 介导的微管蛋白去乙酰化促进三阴性乳腺癌转移,并增加对 HDAC6 抑制剂的敏感性。
Oncogene. 2021 Mar;40(12):2323-2334. doi: 10.1038/s41388-021-01655-2. Epub 2021 Mar 2.
6
HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation.HDAC6 抑制剂使非间充质三阴性乳腺癌细胞对半胱氨酸缺乏敏感。
Sci Rep. 2021 May 26;11(1):10956. doi: 10.1038/s41598-021-90527-6.
7
Identification of a novel PAK1/HDAC6 dual inhibitor ZMF-23 that triggers tubulin-stathmin regulated cell death in triple negative breast cancer.鉴定一种新型 PAK1/HDAC6 双重抑制剂 ZMF-23,其可触发三阴性乳腺癌中微管蛋白-微管稳定蛋白调控的细胞死亡。
Int J Biol Macromol. 2023 Nov 1;251:126348. doi: 10.1016/j.ijbiomac.2023.126348. Epub 2023 Aug 14.
8
Anti-metastatic activity of MPT0G211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo.新型 HDAC6 抑制剂 MPT0G211 在人乳腺癌细胞体外和体内的抗转移活性。
Biochim Biophys Acta Mol Cell Res. 2019 Jun;1866(6):992-1003. doi: 10.1016/j.bbamcr.2019.03.003. Epub 2019 Mar 10.
9
Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer.多种筛查方法揭示HDAC6是三阴性乳腺癌糖酵解代谢的新型调节因子。
Sci Adv. 2021 Jan 15;7(3). doi: 10.1126/sciadv.abc4897. Print 2021 Jan.
10
Acetylation of intrinsically disordered regions regulates phase separation.乙酰化修饰调控无序区域的液-液相分离。
Nat Chem Biol. 2019 Jan;15(1):51-61. doi: 10.1038/s41589-018-0180-7. Epub 2018 Dec 10.

引用本文的文献

1
Aberrant Enhancer Regulation, Phase Separation, and Autoimmune Diseases.异常增强子调控、相分离与自身免疫性疾病
Clin Rev Allergy Immunol. 2025 Aug 27;68(1):84. doi: 10.1007/s12016-025-09096-5.
2
Biomolecular phase separation in tumorigenesis: from aberrant condensates to therapeutic vulnerabilities.肿瘤发生中的生物分子相分离:从异常凝聚物到治疗靶点
Mol Cancer. 2025 Aug 23;24(1):220. doi: 10.1186/s12943-025-02428-1.
3
Phosphorylation of KIAA1429 promotes oxaliplatin resistance through activating the FZD7-Wnt signaling in BRAF-mutated colorectal cancer.

本文引用的文献

1
Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases.通过靶向 DRP1 限制线粒体可塑性可诱导代谢重编程并减少乳腺癌脑转移。
Nat Cancer. 2023 Jun;4(6):893-907. doi: 10.1038/s43018-023-00563-6. Epub 2023 May 29.
2
Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer.三阴性乳腺癌中受体 ER、PR 和 HER2 的缺失会促进 USP15 依赖性 PARP1 的稳定。
Nat Cancer. 2023 May;4(5):716-733. doi: 10.1038/s43018-023-00535-w. Epub 2023 Apr 3.
3
Curriculum vitae of HDAC6 in solid tumors.
KIAA1429的磷酸化通过激活BRAF突变型结直肠癌中的FZD7-Wnt信号通路促进奥沙利铂耐药。
J Exp Clin Cancer Res. 2025 Jul 3;44(1):187. doi: 10.1186/s13046-025-03449-w.
4
Phase Separation in Chromatin Organization and Human Diseases.染色质组织中的相分离与人类疾病
Int J Mol Sci. 2025 May 28;26(11):5156. doi: 10.3390/ijms26115156.
5
CREPT is required for the metastasis of triple-negative breast cancer through a co-operational-chromatin loop-based gene regulation.通过基于合作染色质环的基因调控,CREPT是三阴性乳腺癌转移所必需的。
Mol Cancer. 2025 Jun 10;24(1):170. doi: 10.1186/s12943-025-02361-3.
6
Identification of chromatin remodeling-related gene signature to predict the prognosis in breast cancer.鉴定与染色质重塑相关的基因特征以预测乳腺癌的预后。
Clin Exp Med. 2025 May 3;25(1):137. doi: 10.1007/s10238-025-01661-8.
7
Discovery and biological evaluation of a novel and highly potent JAK2 inhibitor for the treatment of triple negative breast cancer.一种用于治疗三阴性乳腺癌的新型高效JAK2抑制剂的发现与生物学评价
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2488127. doi: 10.1080/14756366.2025.2488127. Epub 2025 Apr 29.
8
Membraneless Organelles and Phase Separation in Tumours: Mechanisms and Prospects.肿瘤中的无膜细胞器与相分离:机制与前景
Cell Prolif. 2025 Aug;58(8):e70027. doi: 10.1111/cpr.70027. Epub 2025 Apr 11.
9
Histone acetylation modulators in breast cancer.乳腺癌中的组蛋白乙酰化调节剂
Breast Cancer Res. 2025 Mar 31;27(1):49. doi: 10.1186/s13058-025-02006-9.
10
A 3D genome view of colon cancer initiation.结肠癌起始的三维基因组视图。
Nat Cancer. 2024 Nov;5(11):1600-1601. doi: 10.1038/s43018-024-00825-x.
固体肿瘤中 HDAC6 的简历。
Int J Biol Macromol. 2023 Mar 1;230:123219. doi: 10.1016/j.ijbiomac.2023.123219. Epub 2023 Jan 13.
4
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer.基于网络的 HDAC6 活性评估可预测乳腺癌患者对 HDAC6 抑制剂 ricolinostat 的临床前和临床反应。
Nat Cancer. 2023 Feb;4(2):257-275. doi: 10.1038/s43018-022-00489-5. Epub 2022 Dec 30.
5
Targeting androgen receptor phase separation to overcome antiandrogen resistance.靶向雄激素受体相分离以克服抗雄激素耐药性。
Nat Chem Biol. 2022 Dec;18(12):1341-1350. doi: 10.1038/s41589-022-01151-y. Epub 2022 Oct 13.
6
Phase separation of Ddx3xb helicase regulates maternal-to-zygotic transition in zebrafish.Ddx3xb 解旋酶的相分离调控斑马鱼的母源到合子的转变。
Cell Res. 2022 Aug;32(8):715-728. doi: 10.1038/s41422-022-00655-5. Epub 2022 Jun 3.
7
Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance.建立 H3K9 甲基化异染色质及其在组织分化和维持中的功能。
Nat Rev Mol Cell Biol. 2022 Sep;23(9):623-640. doi: 10.1038/s41580-022-00483-w. Epub 2022 May 13.
8
Comprehensive 3D epigenomic maps define limbal stem/progenitor cell function and identity.全面的三维表观基因组图谱定义了角膜缘干细胞/祖细胞的功能和特性。
Nat Commun. 2022 Mar 11;13(1):1293. doi: 10.1038/s41467-022-28966-6.
9
Liquid-liquid phase separation drives cellular function and dysfunction in cancer.液液相分离驱动癌症中的细胞功能和功能障碍。
Nat Rev Cancer. 2022 Apr;22(4):239-252. doi: 10.1038/s41568-022-00444-7. Epub 2022 Feb 11.
10
14-3-3 Proteins are Potential Regulators of Liquid-Liquid Phase Separation.14-3-3 蛋白是液-液相分离的潜在调节剂。
Cell Biochem Biophys. 2022 Jun;80(2):277-293. doi: 10.1007/s12013-022-01067-3. Epub 2022 Feb 10.